Company intelligence / Profile preview

Elixir Therapeutics

Ownership: Private
Development stage: Other

Overview

Elixir Therapeutics supplies personal protective equipment (PPE) and medical supplies, such as masks and gowns, primarily for first responders, hospitals, healthcare facilities, schools, and government agencies. The company was founded by Martin Hudler and Shahriar Shahid in response to vulnerabilities in the healthcare supply chain highlighted during major disasters like Hurricanes Sandy and Katrina. Their mission initially focused on supporting the COVID‑19 pandemic response with PPE distribution.

Industry: Consumable Medical Devices

Partnerships

None publicly listed

Beyond the preview

Go deeper on Elixir Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elixir Therapeutics.

Explore the full profile